Efficacy and safety of switching to coformulated elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide (E/C/F/TAF) in virologically suppressed women
Journal of Acquired Immune Deficiency Syndromes | May 27, 2018
Burden of exposure to potential interactions between antiretroviral and non-antiretroviral medications in a population of HIV-positive patients aged 50 years or older
Journal of Acquired Immune Deficiency Syndromes | May 26, 2018